Table 3 Survival analyses of first-line therapeutics for Lyme disease using a propensity-score-matched cohort.
Medication | Disease (ICD9) | ICD9 | P value (LogRank) | Hazard Ratio (90% CI) | P value (Cox) |
---|---|---|---|---|---|
Doxycycline | Tear film insuffic NOS | 375.15 | 6.08E-02 | 2.65 (1.09–6.45) | 7.13E-02 |
Doxycycline | Cataract NOS | 366.9 | 6.72E-02 | 1.9 (1.06–3.42) | 7.18E-02 |
Doxycycline | Chronic rhinitis | 472.0 | 3.60E-02 | 0.49 (0.28–0.87) | 3.99E-02 |
Doxycycline | Backache NOS | 724.5 | 1.67E-02 | 0.42 (0.23–0.78) | 2.03E-02 |
Amoxicillin | Acute URI NOS | 465.9 | 7.41E-03 | 2.26 (1.35–3.78) | 9.13E-03 |